Literature DB >> 7398680

Multidose studies in the human metabolism of pentobarbitone.

W C Baldeo, J N Gilbert, J W Powell.   

Abstract

The metabolism of pentobarbitone has been investigated in two healthy volunteers, and the urinary excretion of unchanged drug, and the products of omega- and (omega-1)-oxidation, quantified for four days after each of three doses to each volunteer. The rates of excretion are discussed in terms which include enzyme induction effects.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7398680     DOI: 10.1007/BF03189449

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  18 in total

1.  The interaction of barbiturates with serum albumin and its possible relation to their disposition and pharmacological actions.

Authors:  L R GOLDBAUM; P K SMITH
Journal:  J Pharmacol Exp Ther       Date:  1954-06       Impact factor: 4.030

2.  Ethyl (3-hydroxy-1-methylbutyl) barbituric acids as metabolites of pentobarbital.

Authors:  E W MAYNERT; J M DAWSON
Journal:  J Biol Chem       Date:  1952-03       Impact factor: 5.157

3.  Metabolism of quinalbarbitone.

Authors:  J N Gilbert; W L Hetherington; J W Powell; W B Whalley
Journal:  J Pharm Pharmacol       Date:  1975-05       Impact factor: 3.765

4.  N-Hydroxyamylobarbitone--a metabolite of amylobarbitone?

Authors:  J N Gilbert; P T Nelmes; J W Powell; S Murray
Journal:  J Pharm Pharmacol       Date:  1978-09       Impact factor: 3.765

5.  Pharmacokinetics and distribution properties of pentobarbital in humans following oral and intravenous administration.

Authors:  M Ehrnebo
Journal:  J Pharm Sci       Date:  1974-07       Impact factor: 3.534

6.  Effect of physicochemical and pharmacokinetic properties of barbiturates on the induction of drug metabolism.

Authors:  O Pelkonen; N T Kärki
Journal:  Chem Biol Interact       Date:  1973-08       Impact factor: 5.192

7.  Synthesis and absolute stereochemistry of 5-alkyl-5-(3'-hydroxy-1'-methylbutyl)barbituric acid and 5-alkyl-5-(3'-hydroxy-1'-methylbutyl)-2-thiobarbituric acids.

Authors:  F I Carroll; G N Mitchell
Journal:  J Med Chem       Date:  1975-01       Impact factor: 7.446

8.  Distinctive patterns of amobarbital metabolites.

Authors:  W Kalow; B K Tang; D Kadar; T Inaba
Journal:  Clin Pharmacol Ther       Date:  1978-11       Impact factor: 6.875

9.  Hydantoin ring glucuronidation: characterization of a new metabolite of 5,5-diphenylhydantoin in man and the rat.

Authors:  R G Smith; G D Daves; R K Lynn; N Gerber
Journal:  Biomed Mass Spectrom       Date:  1977-08

10.  Pentobarbital elimination in patients with poor renal function.

Authors:  M M Reidenberg; D T Lowenthal; W Briggs; M Gasparo
Journal:  Clin Pharmacol Ther       Date:  1976-07       Impact factor: 6.875

View more
  4 in total

Review 1.  Pharmacodynamics and pharmacokinetics of thiopental.

Authors:  H Russo; F Bressolle
Journal:  Clin Pharmacokinet       Date:  1998-08       Impact factor: 6.447

2.  Time-dependent pharmacokinetics of high dose thiopental infusion in intensive care patients.

Authors:  H Russo; M P Dubboin; F Bressolle; S Urien
Journal:  Pharm Res       Date:  1997-11       Impact factor: 4.200

3.  Identification of the diastereomers of pentobarbital N-glucosides excreted in human urine.

Authors:  W H Soine; P J Soine; T M England; R M Graham; G Capps
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

Review 4.  Clinical pharmacokinetic considerations in the treatment of increased intracranial pressure.

Authors:  G Heinemeyer
Journal:  Clin Pharmacokinet       Date:  1987-07       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.